The Angina Pectoris Drugs Market is experiencing steady growth as the global burden of cardiovascular diseases continues to rise. According to Polaris Market Research, the market was valued at USD 11.76 billion in 2024 and is projected to grow from USD 12.20 billion in 2025 to USD 17.25 billion by 2034, registering a CAGR of 3.9% during 2025–2034. The market is being driven by the...